Compare the effects of intrathecal hyperbaric ??????Bupivacaine injected at different doses in combination with a fixed dose of Sufentanil in Cesarean section

Compare the effects of intrathecal hyperbaric Bupivacaine injected at different doses in combination with a fixed dose of Sufentanil in Cesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017010931852N1

Enrollment

105

Registered

2017-03-11

Start date

2017-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy. Caesarean section

Interventions

Intervention 1: A: Intratechal injection of 8 mg hyperbaric Bupivacaine with 2.5 micg Sufentanil. Intervention 2: B: Intratechal injection of 9 mg hyperbaric Bupivacaine with 2.5 micg Sufentanil. Inte

Treatment - Drugs

A: Intratechal injection of 8 mg hyperbaric Bupivacaine with 2.5 micg Sufentanil

B: Intratechal injection of 9 mg hyperbaric Bupivacaine with 2.5 micg Sufentanil

C: Intratechal injection of 10 mg hyperbaric Bupivacaine with 2.5 micg Sufentanil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Not Preeclampsia; ASA36weeks; Not twain; Height>150cm; Not addiction; Not spinal block contraindication Exclusion criteria: Spinal block technical problems

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sensory block level. Timepoint: Every 5 minutes. Method of measurement: Pin prick test.;Motor block level. Timepoint: Every 5 minutes. Method of measurement: Bromage score.	—

Secondary

Measure	Time frame
Nausea. Timepoint: Operation time and Recovery. Method of measurement: Patient statement.;Vomiting. Timepoint: Operation time and Recovery. Method of measurement: Patient status.;Itching. Timepoint: Operation time and Recovery. Method of measurement: Patient statement.;Hypotention. Timepoint: Every 5 minutes. Method of measurement: Non Invasive Blood Pressure measuring.;Bradycardia. Timepoint: Every 5 minutes. Method of measurement: Pulseoxymetery.	—

Measure

Time frame

Nausea. Timepoint: Operation time and Recovery. Method of measurement: Patient statement.;Vomiting. Timepoint: Operation time and Recovery. Method of measurement: Patient status.;Itching. Timepoint: Operation time and Recovery. Method of measurement: Patient statement.;Hypotention. Timepoint: Every 5 minutes. Method of measurement: Non Invasive Blood Pressure measuring.;Bradycardia. Timepoint: Every 5 minutes. Method of measurement: Pulseoxymetery.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRajabi Alireza

Iran University of Medical Science

rajabi.email@yahoo.com+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026